Idenix Pharmaceuticals to Present at the Wells Fargo Securities 2013 Healthcare Conference

Idenix Pharmaceuticals to Present at the Wells Fargo Securities 2013
Healthcare Conference

CAMBRIDGE, Mass., June 11, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals,
Inc. (Nasdaq:IDIX) announced today that Idenix management will present a
corporate overview at the Wells Fargo Securities 2013 Healthcare Conference on
Tuesday, June 18, 2013, at 1:10 p.m. ET at the InterContinental Hotel in
Boston, MA. Management will also participate in a panel discussion on
Hepatitis C earlier in the day at 10:00 a.m. ET. 

The live and archived webcast of the Company presentation can be accessed
under "Events and Presentations" in the Idenix Investor Center at
www.idenix.com. The archived replay will be available on the Idenix website
for two weeks following the conference.

ABOUT IDENIX PHARMACEUTICALS

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical Company engaged in the discovery and development of drugs
for the treatment of human viral diseases. Idenix's current focus is on the
treatment of patients with hepatitis C virus (HCV) infection. For further
information about Idenix, please refer to www.idenix.com.

CONTACT: Teri Dahlman
         (617) 995-9807

Idenix Pharmaceuticals logo
 
Press spacebar to pause and continue. Press esc to stop.